Effect of Olanzapine on Metabolic Syndrome- A One Year Follow-up StudyCorrespondence Address :
Dr. Suvarna Jyothi Kantipudi,
Department of Psychiatry, Sri Ramachandra Institute of Higher Education and Research (SRIHER), Porur, Chennai-600116, Tamil Nadu, India.
Introduction: Patients with schizophrenia have increased risk of cardiovascular mortality and this is partly attributed to antipsychotics. Olanzapine, one of first line antipsychotic for the management of schizophrenia is associated with Metabolic syndrome (MetS). There is paucity of follow-up studies on course of metabolic parameters with olanzapine.
Aim: To understand the effect of olanzapine on weight, fasting blood glucose, Triglycerides (TG), High Density Lipoprotein (HDL), and Waist Circumference (WC) in patients with schizophrenia.
Materials and Methods: This was a prospective observational study where metabolic parameters of patients with schizophrenia were assessed prior to initiation of olanzapine and after one year. Physical health (Blood Pressure (BP), WC, Weight) and laboratory indices (fasting blood sugar, HDL and TG) were evaluated and compared. The association between qualitative variables were assessed using chi-square test and differences in metabolic parameters before and after olanzapine was assessed using paired t-test.
Results: The prevalence of MetS before initiation of olanzapine was 15.4% which increased to 56.9% in one year as per Adult Treatment Protocol of the National Cholesterol Education Program (NCEP ATP III) criteria. There was statistically significant difference in weight, fasting blood glucose, TG, HDL and WC at the end of one year when compared to baseline (p-value <0.05).
Conclusion: Olanzapine has high propensity to derange metabolic parameters in patients with schizophrenia. Close monitoring and lifestyle modification is advised to prevent adverse metabolic effects of olanzapine.
Cardiometabolic risk factors, Psychosis, Schizophrenia, Second generation antipsychotic
Date of Submission: Apr 04, 2020
Date of Peer Review: Apr 20, 2020
Date of Acceptance: Apr 29, 2020
Date of Publishing: Jun 01, 2020
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Apr 06, 2020
• Manual Googling: Apr 28, 2020
• iThenticate Software: May 22, 2020 (12%)
ETYMOLOGY: Author Origin
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)